Gastroenterology Disposables Market Segmentation:
Application Segment Analysis
Based on the application, the therapeutic segment in the gastroenterology disposables market is anticipated to garner the largest share of 67.5% by the end of 2035. The segment’s upliftment is highly attributed to its role in promoting health, well-being, and healing through communication, treatments, and therapeutic relationships. According to an article published by NLM in May 2023, pancreatic cancer is an aggressive neoplasm, with a 5-year survival rate ranging from 5% to 8% within 5 months. Therefore, to combat this, a robust therapeutic alliance is required to foster trust, efficient care, and standard treatment to help patients create coping techniques, thus suitable for the segment’s development.
End user Segment Analysis
Based on end user, the hospitals segment in the gastroenterology disposables market is projected to account for the second-largest share during the forecast duration. The segment’s growth is highly driven by its role as the primary facility for high-acuity and complicated therapeutic procedures, including emergency interventions and endoscopic mucosal resection (EMR) for GI bleeding. This requires wide-ranging infrastructure and multidisciplinary teams. Besides, increased patient footfall for gastroscopies and diagnostic colonoscopies ensures significant volume, making it suitable for the segment’s upliftment.
Procedure Segment Analysis
Based on the procedure, the colonoscopy segment in the gastroenterology disposables market is expected to constitute the third-largest share by the end of the projected timeline. The segment’s development is highly fueled by its importance to prevent and screen colorectal cancer by identifying and overcoming pre-cancerous polyps, and also aids in treating and diagnosing intestinal disorders. As per the April 2025 National Cancer Institute article, 72.6% of adults aged between 50 and 75 years were affected by colorectal cancer as of 2023, and received standard screening based on current medical guidelines. Besides, there will be an increase in the adult population by 74.4% to receive colorectal screening test, thus driving the segment’s exposure.
Our in-depth analysis of the market includes the following segments:
|
Segment |
Subsegments |
|
Application |
|
|
End user |
|
|
Procedure |
|
|
Product |
|
|
Usability |
|
|
Level of Care |
|
